12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice

Type 1 diabetes (T1D) is characterized by the autoimmune destruction of insulin-producing β cells and involves an interplay between β cells and cells of the innate and adaptive immune systems. We investigated the therapeutic potential of targeting 12-lipoxygenase (12-LOX), an enzyme implicated in in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Titli Nargis, Charanya Muralidharan, Jacob R. Enriquez, Jiayi E. Wang, Kerim B. Kaylan, Advaita Chakraborty, Sarida Pratuangtham, Kayla Figatner, Jennifer B. Nelson, Sarah C. May, Jerry L. Nadler, Matthew B. Boxer, David J. Maloney, Sarah A. Tersey, Raghavendra G. Mirmira
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical investigation 2024-12-01
Colecção:	JCI Insight
Assuntos:	Endocrinology Therapeutics
Acesso em linha:	https://doi.org/10.1172/jci.insight.185299
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!